Dr. Osama Abdul-Rahim, MD

Dr. Abdul-Rahim practices at Stride Healthcare in Dallas, Texas.

Dr. Abdul-Rahim's NPI, 1568774065, was assigned on July 13, 2010. Dr. Abdul-Rahim graduated from Drexel University College Of Medicine in 2010. Dr. Abdul-Rahim holds Texas license S9444.

Dr. Abdul-Rahim's primary practice is Stride Healthcare, at 8135 Forest Ln, Dallas, TX 75230 in Dallas County. The practice phone is (866) 552-4866.

Dr. Abdul-Rahim's primary practice is Stride Healthcare in Dallas, Texas. The medical group on file is StrideCare. Dmand AI also links Dr. Abdul-Rahim to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abdul-Rahim practices. Vendor and product names are available with a free account.

Vascular and interventional radiology is Dr. Abdul-Rahim's primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Dr. Abdul-Rahim is board certified in interventional radiology and diagnostic radiology by the American Board of Radiology. Dmand AI has Dr. Abdul-Rahim's licenses on file in 6 states: Texas, Oklahoma, Florida, Georgia, Alabama and Pennsylvania.

CMS data shows 3,560 Medicare services from Dr. Abdul-Rahim across 26 procedure codes in 2024, for 544 Medicare patients. Medicare paid $1,555,982 for them. Every service was in an office.

CMS counts 544 Medicare patients who saw Dr. Abdul-Rahim in 2024. The largest group is 65 to 74, with 245 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abdul-Rahim's median patient age at 74, with 61% women.

In 2024, Dr. Abdul-Rahim wrote 195 Medicare Part D claims for 63 patients. 81% of them were for generic drugs. CMS names the drug for 152 of them, across 2 drugs with 11 or more claims each, at $23,227 in total drug cost. In 2023, CMS named 116 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 71 out of 100 for Dr. Abdul-Rahim for performance year 2024, reported as part of a group. Dr. Abdul-Rahim accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 904 procedures of varicose vein removal by Dr. Abdul-Rahim, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Dr. Abdul-Rahim, published from 2018 to 2020. The most frequent topics are Pancreatic Neoplasms. Dr. Abdul-Rahim has published most often in J Cancer Res Ther. Dr. Abdul-Rahim's most frequent co-authors are Moh'D M Th Khushman, MD, Laith I. Abushahin, MBBS and Omar Alkharabsheh, MD.

CMS Open Payments shows 191 general payments to Dr. Abdul-Rahim from 30 drug and device companies from 2016 to 2025. Device or supply loans make up the largest share, 71% of the total. AngioDynamics, Inc. paid the most, $27,683.

Dr. Abdul-Rahim graduated from Drexel University College Of Medicine in 2010.

Dr. Abdul-Rahim is in network with 23 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.